Evidence map›Paper›PMID 23025260›Full record

ArticleBioData mining2012

GAMETES: a fast, direct algorithm for generating pure, strict, epistatic models with random architectures.

Ryan J Urbanowicz, Jeff Kiralis, Nicholas A Sinnott-Armstrong, Tamra Heberling, Jonathan M Fisher, Jason H Moore

Open access · goldAbstract read
In one paragraph

Article in BioData mining, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 71 papers.

0numbers the graph read from it
0cells of the map it votes in
71citing papers in PubMed
6.8field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

71 citing papers in PubMed, 226 citations in OpenAlex.

  1. Article
  2. Phase-Alternation and Tree-Initialization to Facilitate Interpretable Rule-based Machine Learning.Genetic and Evolutionary Computation Conference : [proceedings]. Genetic and Evolutionary Computation Conference · 2026
    Article
  3. Survival-LCS: Rule-Based Survival Analysis without Proportional Hazard Assumptions.ACM transactions on evolutionary learning and optimization · 2026
    Article
  4. Article
  5. Rule-based Machine Learning: Separating Rule and Rule-Set Pareto-Optimization for Interpretable Noise-Agnostic Modeling.Genetic and Evolutionary Computation Conference : [proceedings]. Genetic and Evolutionary Computation Conference · 2025
    Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

11 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Ryan J UrbanowiczDepartment of Genetics, Institute for Quantitative Biomedical Sciences, Dartmouth Medical School, Lebanon, NH, USA. jason.h.moore@dartmouth.edu.
Jeff Kiralis
Nicholas A Sinnott-Armstrong
Tamra Heberling
Jonathan M Fisher
Jason H Moore
Dartmouth College · US

Funding

Quantitative Biology Research InstituteP20GM103534 · NIGMS · DARTMOUTH COLLEGE · PI AMOS, CHRISTOPHER I. · 2012 to 2016
$8.6M
Bioinformatics Strategies: Biodefense Vaccine ResearchR01AI059694 · NIAID · DARTMOUTH COLLEGE · PI MOORE, JASON H. · 2004 to 2012
$4.5M
Machine Learning Prediction of Cancer SusceptibilityR01LM009012 · NLM · UNIVERSITY OF PENNSYLVANIA · PI MOORE, JASON H. · 2006 to 2014
$3.3M
NIAID NIH HHS R01 AI059694NIGMS NIH HHS P20 GM103534NLM NIH HHS R01 LM009012
6 · The paper itself

Abstract

backgroundGeneticists who look beyond single locus disease associations require additional strategies for the detection of complex multi-locus effects. Epistasis, a multi-locus masking effect, presents a particular challenge, and has been the target of bioinformatic development. Thorough evaluation of new algorithms calls for simulation studies in which known disease models are sought. To date, the best methods for generating simulated multi-locus epistatic models rely on genetic algorithms. However, such methods are computationally expensive, difficult to adapt to multiple objectives, and unlikely to yield models with a precise form of epistasis which we refer to as pure and strict. Purely and strictly epistatic models constitute the worst-case in terms of detecting disease associations, since such associations may only be observed if all n-loci are included in the disease model. This makes them an attractive gold standard for simulation studies considering complex multi-locus effects.

resultsWe introduce GAMETES, a user-friendly software package and algorithm which generates complex biallelic single nucleotide polymorphism (SNP) disease models for simulation studies. GAMETES rapidly and precisely generates random, pure, strict n-locus models with specified genetic constraints. These constraints include heritability, minor allele frequencies of the SNPs, and population prevalence. GAMETES also includes a simple dataset simulation strategy which may be utilized to rapidly generate an archive of simulated datasets for given genetic models. We highlight the utility and limitations of GAMETES with an example simulation study using MDR, an algorithm designed to detect epistasis.

conclusionsGAMETES is a fast, flexible, and precise tool for generating complex n-locus models with random architectures. While GAMETES has a limited ability to generate models with higher heritabilities, it is proficient at generating the lower heritability models typically used in simulation studies evaluating new algorithms. In addition, the GAMETES modeling strategy may be flexibly combined with any dataset simulation strategy. Beyond dataset simulation, GAMETES could be employed to pursue theoretical characterization of genetic models and epistasis.

Identifiers

PMID23025260
PMCPMC3605108
OpenAlexW2126964466

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.